Abcam Plc - Company Profile
Powered by 
All the data and insights you need on Abcam Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Abcam Plc Strategy Report
- Understand Abcam Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteomics tools, proteins and peptides, activators, agonists, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products serve life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific, and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.
Headquarters
United Kingdom
Address
Discovery Drive, Cambridge Biomedical Campus, Hills Road, Cambridgeshire, CB20AX
Website
www.abcam.com
Telephone
44 1223 696000
No of Employees
1,800
Industry
Medical Equipment
Revenue (2022)
$445.8M
Abcam Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Antibodies | RabMab |
| Research-Grade Antibodies | |
| In Vitro Diagnostic (IVD) Antibodies | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Ownership Changes | In December, the company was acquired by Danaher Corp, a global life sciences and diagnostics provider for US$5.7 billion. |
| 2023 | Contracts/Agreements | In April, the company came into agreement for primary antibody validation for use on Comet. |
| 2022 | Contracts/Agreements | In December, the company and WuXiDiagnostics announced a new supply and licensing agreement to support the development of innovative anti-cancer treatments in China. |
Competitor Comparison
| Key Parameters | Abcam Plc | F. Hoffmann-La Roche Ltd | Siemens Healthineers AG | Illumina Inc | bioMerieux SA |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | Switzerland | Germany | United States of America | France |
| City | Cambridge | Basel | Forchheim | San Diego | Craponne |
| State/Province | Cambridgeshire | - | - | California | Rhone Alpes |
| No. of Employees | 1,800 | 103,605 | 71,400 | 10,590 | 14,651 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Alan Hirzel | Director; Chief Executive Officer | Executive Board | 2014 | 55 |
| Michael S. Baldock | Director; Chief Financial Officer | Executive Board | 2020 | 59 |
| Peter Allen | Chairman | Non Executive Board | 2018 | 66 |
| Markus Lusser | President | Senior Management | 2024 | - |
| Tommy Thomas | Vice President - Investor Relations | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward